J.‐E. Damber

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

Anders Widmark, Olbjørn Klepp, Arne Solberg et al.|The Lancet|2008

Cited by 873Open Access

Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search

Jeffrey R. Smith, Diha Freije, John D. Carpten et al.|Science|1996

Cited by 830

Despite its high prevalence, very little is known regarding genetic predisposition to prostate cancer. A genome-wide scan performed in 66 high-risk prostate cancer families has provided evidence of linkage to the long arm of chromosome 1 (1q24-25). Analysis of an additional set of 25 North American and Swedish families with markers in this region resulted in significant evidence of linkage in the combined set of 91 families. The data provide strong evidence of a major prostate cancer susceptibility locus on chromosome 1.

Phytoestrogens and Prostate Disease

Herman Adlercreutz, Witold Mazur, P H Bartels et al.|Journal of Nutrition|2000

Cited by 113

Does prophylactic breast irradiation prevent antiandrogen-induced gynecomastia? Evaluation of 253 patients in the randomized Scandinavian trial SPCG-7/SFUO-3

Anders Widmark, Sophie D. Fosså, P.I. Lundmo et al.|Urology|2003

Cited by 101

Ten- and 15-yr Prostate Cancer-specific Mortality in Patients with Nonmetastatic Locally Advanced or Aggressive Intermediate Prostate Cancer, Randomized to Lifelong Endocrine Treatment Alone or Combined with Radiotherapy: Final Results of The Scandinavian Prostate Cancer Group-7

Sophie D. Fosså, Fredrik Wiklund, Olbjørn Klepp et al.|European Urology|2016

Cited by 88

Is this you? Claim your profile.

Top publicationsby citations